No abstract available
Keywords:
COVID-19; acute renal failure; antiviral; end-stage renal disease.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
Acute Kidney Injury / diagnosis
-
Acute Kidney Injury / drug therapy
-
Acute Kidney Injury / epidemiology*
-
Adenosine Monophosphate / administration & dosage
-
Adenosine Monophosphate / adverse effects
-
Adenosine Monophosphate / analogs & derivatives*
-
Alanine / administration & dosage
-
Alanine / adverse effects
-
Alanine / analogs & derivatives*
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / adverse effects
-
COVID-19
-
Cause of Death*
-
Comorbidity
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / epidemiology*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Humans
-
Injections, Intravenous
-
Kidney Failure, Chronic / diagnosis
-
Kidney Failure, Chronic / drug therapy
-
Kidney Failure, Chronic / epidemiology*
-
Male
-
Massachusetts
-
Pandemics
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / epidemiology*
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Survival Rate
Substances
-
Antiviral Agents
-
remdesivir
-
Adenosine Monophosphate
-
Alanine